Comparison of Dose Escalation and Co-Therapy Intensification Between Patients with Rheumatoid Arthritis Initiating Biologic Treatment with Etanercept, Adalimumab and Infliximab

被引：0
|
作者：
Thorne, J. Carter [1 ]
Boire, Gilles [2 ]
Chow, Andrew [3 ]
Garces, Kirsten [4 ]
Liu, Fang [5 ]
Poulin-Costello, Melanie [4 ]
Walker, Valery [5 ]
Haraoui, Boulos [6 ]
机构：
[1] Southlake Reg Hlth Ctr, Newmarket, ON, Canada
[2] Univ Sherbrooke, Dept Med, Div Rheumatol, Sherbrooke, PQ J1K 2R1, Canada
[3] Credit Valley Rheumatol, Mississauga, ON, Canada
[4] Amgen Canada Inc, Mississauga, ON, Canada
[5] Optum, Burlington, ON, Canada
[6] Inst Rhumatol Montreal, Montreal, PQ, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
548
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comparison of Dose Escalation and Co-therapy Intensification between Patients with Rheumatoid Arthritis Initiating Biologic Treatment with Etanercept, Adalimumab and Infliximab
    Thorne, Carter
    Boire, Gilles
    Chow, Andrew
    Garces, Kirsten
    Poulin-Costello, Melanie
    Walker, Valery
    Haraoui, Boulos
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1171 - 1171
  • [2] COMPARISON OF DOSE ESCALATION AND COSTS OF DOSE ESCALATION BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGIC TREATMENT WITH ETANERCEPT, ADALIMUMAB, OR INFLIXIMAB
    Garces, K.
    Thorne, C.
    Boire, G.
    Chow, A.
    Poulin-Costello, M.
    Walker, V
    Haraoui, B.
    VALUE IN HEALTH, 2016, 19 (03) : A229 - A230
  • [3] Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: A systematic review of cohort studies with focus on dose
    Eng, Grith
    Stoltenberg, Michael B.
    Szkudlarek, Marcin
    Bouchelouche, Pierre N.
    Christensen, Robin
    Bliddal, Henning
    Bartels, Else Marie
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 43 (02) : 144 - 151
  • [4] A difference in effectiveness between infliximab, etanercept and adalimumab in patients with rheumatoid arthritis.
    Kievit, Wietske
    Fransen, Jaap
    Kuper, Ina H.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    De Rooij, Dirk jan R. A. M.
    de Gendt, Carla M.
    Ronday, Karel H.
    Brus, Herman L. M.
    van Ooijen, Piet C. M.
    van Riel, Piet C. L. M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S309 - S310
  • [5] COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING
    Gokhale, S. B.
    Cassel, T.
    Mahon, R.
    Balkin, P. E.
    Singh, S.
    Bhattacharyya, S.
    Handin, J.
    Mendoza, C.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
  • [6] Dose intensification with infliximab in patients with rheumatoid arthritis
    Berger, A
    Edelsberg, J
    Li, TT
    Maclean, JR
    Oster, G
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (12) : 2021 - 2025
  • [7] Treatment Patterns and Costs in Biologic DMARD-Naive Patients with Rheumatoid Arthritis Initiating Etanercept or Adalimumab with or Without Methotrexate
    Tkacz, Joseph
    Gharaibeh, Mahdi
    DeYoung, Kathryn Henderson
    Wilson, Kathleen
    Collier, David
    Oko-osi, Hafiz
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (03): : 285 - 294
  • [8] OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING THERAPY WITH ETANERCEPT, ADALIMUMAB, OR JANUS KINASE INHIBITORS
    Pappas, D. A.
    O'brien, J.
    Guo, L.
    Shan, Y.
    Baker, J.
    Kricorian, G.
    Stryker, S.
    Collier, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 529 - 530
  • [9] Outcomes in Patients with Rheumatoid Arthritis Initiating Therapy with Etanercept, Adalimumab, or Janus Kinase Inhibitors
    Pappas, Dimitrios
    O'Brien, Jacqueline
    Guo, Lin
    Shan, Ying
    Baker, Joshua
    Kricorian, Gregory
    Stryker, Scott
    Collier, David
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 856 - 857
  • [10] Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
    Neovius, M.
    Arkema, E. V.
    Olsson, H.
    Eriksson, J. K.
    Kristensen, L. E.
    Simard, J. F.
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 354 - 360
12345